Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
62.05 USD | +2.43% | +2.01% | -35.57% |
05-29 | BofA Securities Adjusts Crane Price Target to $165 From $140, Maintains Buy Rating | MT |
05-27 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.94% | 12.14B | |
-7.82% | 6.33B | |
+42.14% | 2.12B | |
+5.58% | 1.55B | |
+11.55% | 909M | |
+3.43% | 893M | |
-7.63% | 662M | |
-14.28% | 622M | |
-27.32% | 381M |
- Stock Market
- Equities
- CR Stock
- CXT Stock
- News Crane NXT
- BofA Securities Adjusts Price Target for Crane Co to $115 From $131, Maintains Buy Rating